Paloma Giangrande was Appointed as Chief Technology Officer at Eleven Therapeutics

Date of management change: January 11, 2024 

What Happened?

Cambridge, MA-based Eleven Therapeutics Appointed Paloma Giangrande as Chief Technology Officer

 

About the Company

Eleven Therapeutics is at the forefront of mRNA therapeutics innovation, harnessing combinatorial chemistry, synthetic biology, and artificial intelligence to develop next-generation therapies. The company`s pipeline includes extended-release mRNA therapeutics (xRNA) targeting unmet medical needs in metabolic, hematologic, and infectious disease areas. Proprietary high-throughput screening platforms, TERA™ and DELiveri™, underpin Eleven Therapeutics` pipeline by generating chemically modified xRNAs and cell-penetrating delivery carriers. Founded in 2020 by world-leading scientists across Cambridge (UK), Boston (US), and Tel Aviv (Israel), Eleven Therapeutics is supported by top-tier venture capitalists and the Bill & Melinda Gates Foundation.

 

About the Person

Paloma Giangrande is Chief Technology Officer at Eleven Therapeutics. Previously, Paloma held various senior IT leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Paloma Giangrande

Title: Chief Technology Officer

Company: Eleven Therapeutics

Industry: Biotechnology

imageCurrent Contact Info

 

Email: ******@eleventx.com 

Phone:.***.***.*91* 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: Newton Rusty, Kadavy Heather, Maxwell Phillip, Wiltshire Martyn, Frank Bob, Johnson Richard, McGarrity Mark, Atanasov Ves, McKinney Brenton, Deckard Carl, Wise Deanna

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.